MT-1

Melanotan 1, also known as afamelanotide, is a lab-made version of a hormone your body already produces called alpha-melanocyte stimulating hormone, or alpha-MSH for short. That natural hormone tells certain skin cells called melanocytes to start making melanin, the pigment that gives your skin its color and helps protect it from sun damage. The problem is that your body's natural version of this hormone breaks down almost immediately, so scientists at the University of Arizona in the 1980s engineered MT-1 to be up to 26 times more potent and far more stable, making it practical for actual therapeutic use. In October 2019, the FDA approved MT-1 under the brand name Scenesse as a subcutaneous implant for treating erythropoietic protoporphyria, a rare genetic condition that causes extreme and painful sensitivity to sunlight.

What makes MT-1 stand out from its more famous relative, Melanotan 2, is how precisely it targets the specific receptor responsible for skin pigmentation without triggering a cascade of other effects throughout the body. While MT-2 activates a whole family of melanocortin receptors that influence appetite, sexual arousal, and more, MT-1 homes in on just one receptor, MC1R, the one that controls melanin production. This selectivity means you get the tanning and photoprotective benefits without the broader systemic side effects that many people experience with MT-2, such as appetite suppression or unwanted changes in libido.

Beyond cosmetic tanning, MT-1 has generated serious clinical interest for conditions like vitiligo, where patches of skin lose their pigment, and polymorphic light eruption, a type of sun allergy. It is also the only melanocortin-based peptide to have earned full FDA approval, giving it a level of safety documentation and clinical scrutiny that no other tanning peptide can match. For people who want the benefits of increased melanin, whether for appearance, sun protection, or managing a medical condition, MT-1 represents the most well-studied and refined option available.

Think of your skin cells as tiny factories that can produce melanin, a dark pigment that acts like a built-in sunscreen. Each factory has a specific lock on its door called the MC1R receptor, and alpha-MSH is the natural key that fits that lock. When MT-1 enters your body, it acts like a much stronger, longer-lasting copy of that key. It binds to the MC1R receptor on your melanocytes, essentially flipping the switch that tells those factories to ramp up melanin production. The melanin then gets distributed outward to the surrounding skin cells called keratinocytes, gradually darkening your skin over the course of days and weeks.

The reason MT-1 is considered a cleaner compound than MT-2 comes down to selectivity. Your body has several different melanocortin receptors, numbered MC1R through MC5R, and each one controls different functions. MC1R handles pigmentation, MC4R is involved in appetite and sexual arousal, and the others play various roles in inflammation and energy balance. MT-2 is like a master key that opens multiple doors at once, which is why it causes tanning but also suppresses appetite and increases libido. MT-1, by contrast, is much more selective for the MC1R lock specifically, so it triggers melanin production with minimal interference in those other systems.

Once your melanocytes are producing extra melanin, that pigment provides genuine UV protection. Melanin physically absorbs ultraviolet radiation before it can damage the DNA inside your skin cells. Clinical studies showed that people treated with MT-1 had 47% fewer sunburn cells compared to untreated subjects after the same UV exposure. The compound itself has a very short natural half-life of about 30 minutes, which is why the FDA-approved version uses a slow-release implant that extends the effective duration to about 15 hours, with visible pigmentation effects lasting for weeks after each treatment.